[1]
“ Dissolution test optimization for meloxicam in the tablet pharmaceutical form ”, Braz. J. Pharm. Sci., vol. 45, no. 1, pp. 67–73, Mar. 2009, doi: 10.1590/S1984-82502009000100008.